Velasco, Rhenz S.
HRN: 24-77-51 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2024
AMPICILLIN 250MG (VIAL)
03/28/2024
04/25/2024
IV
200mg
Q6
Empiric
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes